Effect of green tea extract on arterial stiffness, lipid profile and sRAGE in patients with type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled trial

References

• Babu PVA, Sabitha KE, Shyamaladevi CS. 2006. Therapeutic effect of green tea extract on advanced glycation and cross‐linking of collagen in the aorta of streptozotocin diabetic rats. Clin Exp Pharmacol Physiol. 33(4):351–357.
   PubMed Web of Science ®Google Scholar
• Borges CM, Papadimitriou A, Duarte DA, De Faria JML, De Faria JBL. 2016. The use of green tea polyphenols for treating residual albuminuria in diabetic nephropathy: a double-blind randomised clinical trial. Sci Rep. 6:28282.
   PubMed Web of Science ®Google Scholar
• Boteanu RM, Suica VI, Uyy E, Ivan L, Dima SO, Popescu I, Simionescu M, Antohe F. 2017. Alarmins in chronic non-communicable diseases: atherosclerosis, diabetes and cancer. J Proteomics. 153:21–29.
   PubMed Web of Science ®Google Scholar
• Cheng TO. 2006. All teas are not created equal: the Chinese green tea and cardiovascular health. Int J Cardiol. 108(3):301–308.
   PubMed Web of Science ®Google Scholar
• Chirinos JA, Zambrano JP, Chakko S, Veerani A, Schob A, Perez G, Mendez AJ. 2005. Relation between ascending aortic pressures and outcomes in patients with angiographically demonstrated coronary artery disease. Am J Cardiol. 96(5):645–648.
   PubMed Web of Science ®Google Scholar
• Curtis PJ, Potter J, Kroon PA, Wilson P, Dhatariya K, Sampson M, Cassidy A. 2013. Vascular function and atherosclerosis progression after 1 y of flavonoid intake in statin-treated postmenopausal women with type 2 diabetes: a double-blind randomized controlled trial. Am J Clin Nutr. 97(5):936–942.
   PubMed Web of Science ®Google Scholar
• Eguchi K, Kuruvilla S, Ogedegbe G, Gerin W, Schwartz JE, Pickering TG. 2009. What is the optimal interval between successive home blood pressure readings using an automated oscillometric device? J Hypertens. 27(6):1172.
   PubMed Web of Science ®Google Scholar
• Grillo A, Parati G, Rovina M, Moretti F, Salvi L, Gao L, Baldi C, Sorropago G, Faini A, Millasseau SC, et al. 2017. Short-term repeatability of noninvasive aortic pulse wave velocity assessment: comparison between methods and devices. Am J Hypertens. 31(1):80–88.
   PubMed Web of Science ®Google Scholar
• Huang SM, Chang YH, Chao YC, Lin JA, Wu CH, Lai CY, Chan KC, Tseng ST, Yen GC. 2013. EGCG-rich green tea extract stimulates sRAGE secretion to inhibit S100A12-RAGE axis through ADAM10-mediated ectodomain shedding of extracellular RAGE in type 2 diabetes. Mol Nutr Food Res. 57(12):2264–2268.
   PubMed Web of Science ®Google Scholar
• Imbalzano E, Mandraffino G, Casciaro M, Quartuccio S, Saitta A, Gangemi S. 2016. Pathophysiological mechanism and therapeutic role of S100 proteins in cardiac failure: a systematic review. Heart Fail Rev. 21(5):463–473.
   PubMed Web of Science ®Google Scholar
• Jeyaseelan L, Rao P. 1989. Methods of determining sample sizes in clinical trials. Indian Pediatr. 26(2):115.
   PubMedGoogle Scholar
• Katakami N. 2018. Mechanism of development of atherosclerosis and cardiovascular disease in diabetes mellitus. J Atheroscler Thromb. 25(1):27–39.
   PubMed Web of Science ®Google Scholar
• Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y, Tsuji I. 2006. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA. 296(10):1255–1265.
   PubMed Web of Science ®Google Scholar
• Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H. 2006. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 27(21):2588–2605.
   PubMed Web of Science ®Google Scholar
• Lekakis J, Rallidis LS, Andreadou I, Vamvakou G, Kazantzoglou G, Magiatis P, Skaltsounis AL, Kremastinos DT. 2005. Polyphenolic compounds from red grapes acutely improve endothelial function in patients with coronary heart disease. Eur J Cardiovasc Prev Rehabil. 12(6):596–600.
   PubMedGoogle Scholar
• Liu CY, Huang CJ, Huang LH, Chen IJ, Chiu JP, Hsu CH. 2014. Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial. PLoS One. 9(3):e91163.
   PubMed Web of Science ®Google Scholar
• Liu H, Wang H. 2016. Early detection system of vascular disease and its application prospect. BioMed Res Int. 2016:1–11.
   Web of Science ®Google Scholar
• Liu K, Zhou R, Wang B, Chen K, Shi L-Y, Zhu J-D, Mi M-T. 2013. Effect of green tea on glucose control and insulin sensitivity: a meta-analysis of 17 randomized controlled trials. Am J Clin Nutr. 98(2):340–348.
   PubMed Web of Science ®Google Scholar
• Momose Y, Maeda-Yamamoto M, Nabetani H. 2016. Systematic review of green tea epigallocatechin gallate in reducing low-density lipoprotein cholesterol levels of humans. Int J Food Sci Nutr. 67(6):606–613.
   PubMed Web of Science ®Google Scholar
• Maillard-Lefebvre H, Boulanger E, Daroux M, Gaxatte C, Hudson BI, Lambert M. 2009. Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases. Rheumatology. 48(10):1190–1196.
   PubMed Web of Science ®Google Scholar
• Martín-Timón I, Sevillano-Collantes C, Segura-Galindo A, del Cañizo-Gómez FJ. 2014. Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength. World J Diabetes. 5(4):4444–470.
   Google Scholar
• Mukherjee S, Mukhopadhyay P, Pandit K, Mukherjee S, Chowdhury S. 2008. Atorvastatin improves arterial stiffness in normotensive normolipidaemic persons with type 2 diabetes. J Indian Med Assoc. 106:716–719.
   PubMedGoogle Scholar
• Mullan BA, Young IS, Fee H, McCance DR. 2002. Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes. Hypertension. 40(6):804–809.
   PubMed Web of Science ®Google Scholar
• Nantz MP, Rowe CA, Bukowski JF, Percival SS. 2009. Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study. Nutrition. 25(2):147–154.
   PubMed Web of Science ®Google Scholar
• Prabhakar PK. 2016. Pathophysiology of secondary complications of diabetes mellitus. Asian J Pharm Clin Res. 9(1):32–36.
   Google Scholar
• Quade-Lyssy P, Kanarek AM, Baiersdorfer M, Postina R, Kojro E. 2013. Statins stimulate the production of a soluble form of the receptor for advanced glycation end products. J Lipid Res. 54(11):3052–3061.
   PubMed Web of Science ®Google Scholar
• Ryu O, Lee J, Lee K, Kim H, Seo J, Kim S, Kim N, Baik S, Choi D, Choi K. 2006. Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res Clin Pract. 71(3):356–358.
   PubMed Web of Science ®Google Scholar
• Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corra U, Cosyns B, Deaton C, et al. 2016. European Guidelines on cardiovascular disease prevention in clinical practice The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) Atherosclerosis. 252:207–274.
   PubMed Web of Science ®Google Scholar
• Salvi P, Parati G. 2012. Augmentation index as a specific marker of large arteries distensibility: the end of a beautiful tale? J Hypertens. 30(12):2276–2278.
   PubMed Web of Science ®Google Scholar
• Samavat H, Newman AR, Wang R, Yuan J-M, Wu AH, Kurzer MS. 2016. Effects of green tea catechin extract on serum lipids in postmenopausal women: a randomized, placebo-controlled clinical trial. Am J Clin Nutr. 104(6):1671–1682.
   PubMed Web of Science ®Google Scholar
• Templeton GF. 2011. A two-step approach for transforming continuous variables to normal: implications and recommendations for IS research. CAIS. 28(1):41–58.
   Google Scholar
• The American Diabetes Association. 2018. Classification and diagnosis of diabetes: standards of medical care in diabetes. Diabetes Care. 41(Suppl. 1):S13–S27.
   PubMedGoogle Scholar
• Uemura H, Katsuura-Kamano S, Yamaguchi M, Nakamoto M, Hiyoshi M, Arisawa K. 2013. Consumption of coffee, not green tea, is inversely associated with arterial stiffness in Japanese men. Eur J Clin Nutr. 67(10):1109.
   PubMed Web of Science ®Google Scholar
• Vazzana N, Santilli F, Cuccurullo C, Davì G. 2009. Soluble forms of RAGE in internal medicine. Intern Emerg Med. 4(5):389–401.
   PubMed Web of Science ®Google Scholar
• Vlachopoulos C, Aznaouridis K, Alexopoulos N, Economou E, Andreadou I, Stefanadis C. 2005. Effect of dark chocolate on arterial function in healthy individuals. Am J Hypertens. 18(6):785–791.
   PubMed Web of Science ®Google Scholar
• Wassertheurer S, Kropf J, Weber T, van der Giet M, Baulmann J, Ammer M, Hametner B, Mayer CC, Eber B, Magometschnigg D. 2010. A new oscillometric method for pulse wave analysis: comparison with a common tonometric method. J Hum Hypertens. 24(8):498–504.
   PubMed Web of Science ®Google Scholar
• Weber T, Wassertheurer S, Rammer M, Maurer E, Hametner B, Mayer CC, Kropf J, Eber B. 2011. Validation of a brachial cuff-based method for estimating central systolic blood pressure. Hypertension. 58(5):825–832.
   PubMed Web of Science ®Google Scholar
• Yamada H, Watanabe H. 2007. Tea polyphenols in preventing cardiovascular diseases. Cardiovasc Res. 73(2):439–440.
   PubMed Web of Science ®Google Scholar
• Yan SF, Ramasamy R, Schmidt AM. 2010. Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging. Biochem Pharmacol. 79(10):1379–1386.
   PubMed Web of Science ®Google Scholar